Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder : Core Common Protocol

First published 17/11/2016

Last updated 02/07/2024

EU PAS number:

EUPAS16088

Study

Finalised

Documents

Study protocol

Initial protocol

178-CL-113_Protocol Version 7.0_For ENCePP Reg

English (625.71 KB - PDF) View document

Updated protocol

178-cl-113-clp-07-reissue-v8dot1-en-final-02

First published: 22/02/2024

English (1.33 MB - PDF) View document

Study results

178-cl-113-clrr-04-disc01-en-final-02

English (904.23 KB - PDF) View document

Study report

Other information

Secondary tabs